Cargando…
Coverage and Prior Authorization Policies for Medications for Opioid Use Disorder in Medicaid Managed Care
IMPORTANCE: Medicaid is a key policy lever to improve opioid use disorder treatment, covering approximately 40% of Americans with opioid use disorder. Although approximately 70% of Medicaid beneficiaries are enrolled in comprehensive managed care organization (MCO) plans, little is known about cover...
Autores principales: | Abraham, Amanda J., Andrews, Christina M., Harris, Samantha J., Westlake, Melissa M., Grogan, Colleen M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10157383/ https://www.ncbi.nlm.nih.gov/pubmed/36331441 http://dx.doi.org/10.1001/jamahealthforum.2022.4001 |
Ejemplares similares
-
Changes in Medicaid Fee-for-Service Benefit Design for Substance Use Disorder Treatment During the Opioid Crisis, 2014 to 2021
por: Shoulders, Angela, et al.
Publicado: (2023) -
Medicaid expansion and opioid supply policies to address the opioid overdose crisis
por: Shakya, Shishir, et al.
Publicado: (2022) -
Removal of Medicaid Prior Authorization Requirements and Buprenorphine Treatment for Opioid Use Disorder
por: Christine, Paul J., et al.
Publicado: (2023) -
Buprenorphine Use Trends Following Removal of Prior Authorization Policies for the Treatment of Opioid Use Disorder in 2 State Medicaid Programs
por: Keshwani, Shailina, et al.
Publicado: (2022) -
US state policies for Medicaid coverage of donor human milk
por: Rose, Allison T., et al.
Publicado: (2022)